A portion of the US holdings for this investor are reported in this report and a portion are reported by other reporting manager(s). Top holdings included Infinera Corp 144A 1 3/4% Due 6/1/2018 JD1, Albany Molecular Research Inc Convertible 2 1/4% Due 11/15/2018 MN15, Tesaro Inc 3% Due 10/1/2021 AO1, Insulet Corp Convertible 2% Due 6/15/2019 JD15, and InvenSense Inc. Convertible 144A 1 3/4% Due 11/1/2018 MN1.
Showing stock holdings,
see here
for options holdings
ALTEGRIS ADVISORS, L.L.C. Q4 2014 Portfolio
Sym
Weight
Trade Impact
Company
Class
Share Change
Activity
Value Change $
Value $
* Price $
Shares
Principal
Filing 2014 Q4 compared to 2014 Q3 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
Person Signing this Report on Behalf of Reporting Manager:
Name
Title
City, State
Date
Jon Sundt
President and CEO
La Jolla, California
09 Feb 2015
List of Other Managers Reporting for ALTEGRIS ADVISORS, L.L.C.:
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.